Real-world rivaroxaban use in fragile Asian patients with atrial fibrillation: The impact of plasma concentration on clinical outcomes

Thromb Res. 2022 Oct:218:189-191. doi: 10.1016/j.thromres.2022.08.027. Epub 2022 Sep 3.
No abstract available

Keywords: Atrial fibrillation; Plasma concentration; Rivaroxaban.

Publication types

  • Letter

MeSH terms

  • Anticoagulants / therapeutic use
  • Atrial Fibrillation* / drug therapy
  • Factor Xa Inhibitors / therapeutic use
  • Humans
  • Rivaroxaban* / therapeutic use

Substances

  • Anticoagulants
  • Factor Xa Inhibitors
  • Rivaroxaban